2024-05-02 07:55:40 ET
More on Regeneron Pharmaceuticals
- Regeneron's Triple Threat: Eylea, Libtayo, And Dupixent Dominate
- Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners Global Biopharma Conference (Transcript)
- Regeneron Pharmaceuticals, Inc. (REGN) Barclays 26th Annual Global Healthcare Conference (Transcript)
- Regeneron Pharmaceuticals misses top-line and bottom-line estimates; updates FY24 outlook
- Regeneron Pharmaceuticals Q1 2024 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Regeneron falls after Q1 miss; announces $3B share buybacks